NDC 51662-1291

DOPAMINE HCI

Dopamine Hci

DOPAMINE HCI is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dopamine Hydrochloride.

Product ID51662-1291_763d2b07-9ceb-782e-e053-2a91aa0adc01
NDC51662-1291
Product TypeHuman Prescription Drug
Proprietary NameDOPAMINE HCI
Generic NameDopamine Hci
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-09-19
Marketing CategoryNDA / NDA
Application NumberNDA018132
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameDOPAMINE HYDROCHLORIDE
Active Ingredient Strength40 mg/mL
Pharm ClassesCatecholamine [EPC],Catecholamines [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1291-1

10 mL in 1 VIAL, SINGLE-DOSE (51662-1291-1)
Marketing Start Date2018-09-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1291-1 [51662129101]

DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE
Marketing CategoryNDA
Application NumberNDA018132
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-19
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
DOPAMINE HYDROCHLORIDE40 mg/mL

OpenFDA Data

SPL SET ID:763d2b07-9cea-782e-e053-2a91aa0adc01
Manufacturer
UNII

Pharmacological Class

  • Catecholamine [EPC]
  • Catecholamines [CS]

NDC Crossover Matching brand name "DOPAMINE HCI" or generic name "Dopamine Hci"

NDCBrand NameGeneric Name
51662-1220DOPAMINE HCIDOPAMINE HCI
51662-1291DOPAMINE HCIDOPAMINE HCI

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.